Carfilzomib
20S Proteasome inhibitor
Product Specifications
Background
Carfilzomib / PR-17 is an irreversible proteasome inhibitor that targets the chymotrypsin-like beta5 subunit of 20S proteasome. It can arrest the cell cycle and trigger apoptosis in tumor cell lines.
Product Name Alternative
(αS)-α-[[2-(4-morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-L-phenylalaninamide, PR-17, Carfilzomib, Kyprolis, Carfilzomib (PR-171), PR-171, UNII-72X6E3J5AR
UNSPSC
41116105
Source
Synthetic
Purity
>98% (TLC); NMR (Conforms)
Weight
0.005
Format
White powder
Solubility
Soluble in DMSO (80 mg/ml), or ethanol (25 mg/ml)
Molecular Formula
C40H57N5O7
Molecular Weight
719.9
Precautions
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
CAS Number
868540-17-4
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
